Full Name
Paul Rowe
Job Title
Senior Vice President, Head Of Medical, Specialty Care, Sanofi
Company
Sanofi
Speaker Bio
Dr. Rowe has over two decades of research experience spanning from pre-clinical to late phase innovative medical therapy development programs, primarily in
respiratory (and cardiovascular) medicine within the pharma industry. He has been directly responsible for medical strategy and lifecycle management of several Chronic Obstructive Pulmonary Disease (COPD), asthma, thrombosis, and cardiovascular medicines. Dr. Rowe has been successfully involved in achieving New Drug Application (NDA) approvals for first in therapeutic class respiratory products and has also led various clinical development and medical global projects from phase II through phase IV clinical trials. He has authored and co-authored numerous publications in respiratory medicine (COPD and asthma focused primarily) and is a frequent lecturer and speaker at professional society meetings, and educational forums. Dr. Rowe holds degrees from Harvard University and the University of Rochester School of Medicine, internship in general surgery with additional otolaryngology training, and holds certifications from the London School of Economics and Villanova University.
Dr. Rowe is an active member of several national and international societies and he previously served as Vice Chair of the Drug, Device, Discovery, and Development Committee of the American Thoracic Society (ATS) and has received the distinction of being named a Fellow of the society. He has a primary interest in promoting international medical research collaboration and innovation across government, academia, and industry. Dr. Rowe has a keen interest in the intersection of health equity, AI, and innovative patient care.
Recently, Dr. Rowe was responsible for building and leading a Global Medical team and strategy within the Immunology space for novel compounds in mid and late-stage development, in various therapeutic disease state indications and leading a large medical organization in North America spanning diverse therapeutic areas ranging from Rare Blood Disorders and Neurology to Oncology and Immunology. In his current role, Dr. Rowe is responsible for providing the overall strategic medical direction to the Specialty Care organization worldwide.
respiratory (and cardiovascular) medicine within the pharma industry. He has been directly responsible for medical strategy and lifecycle management of several Chronic Obstructive Pulmonary Disease (COPD), asthma, thrombosis, and cardiovascular medicines. Dr. Rowe has been successfully involved in achieving New Drug Application (NDA) approvals for first in therapeutic class respiratory products and has also led various clinical development and medical global projects from phase II through phase IV clinical trials. He has authored and co-authored numerous publications in respiratory medicine (COPD and asthma focused primarily) and is a frequent lecturer and speaker at professional society meetings, and educational forums. Dr. Rowe holds degrees from Harvard University and the University of Rochester School of Medicine, internship in general surgery with additional otolaryngology training, and holds certifications from the London School of Economics and Villanova University.
Dr. Rowe is an active member of several national and international societies and he previously served as Vice Chair of the Drug, Device, Discovery, and Development Committee of the American Thoracic Society (ATS) and has received the distinction of being named a Fellow of the society. He has a primary interest in promoting international medical research collaboration and innovation across government, academia, and industry. Dr. Rowe has a keen interest in the intersection of health equity, AI, and innovative patient care.
Recently, Dr. Rowe was responsible for building and leading a Global Medical team and strategy within the Immunology space for novel compounds in mid and late-stage development, in various therapeutic disease state indications and leading a large medical organization in North America spanning diverse therapeutic areas ranging from Rare Blood Disorders and Neurology to Oncology and Immunology. In his current role, Dr. Rowe is responsible for providing the overall strategic medical direction to the Specialty Care organization worldwide.
Speaking At
